Skip to content
June 7, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
The Limbo of Survival: Navigating the Intersection of Cancer Recovery and National Conflict in Israel the-limbo-of-survival-navigating-the-intersection-of-cancer-recovery-and-national-conflict-in-israel
  • Patient Advocacy and Support

The Limbo of Survival: Navigating the Intersection of Cancer Recovery and National Conflict in Israel

Asro August 9, 2025 0
JERUSALEM — As the dust begins to settle on a six-week period of intense geopolitical instability, a...
Read More Read more about The Limbo of Survival: Navigating the Intersection of Cancer Recovery and National Conflict in Israel
A Crisis of Humanity: A Decade of Broken Promises on Healthcare in Conflict a-crisis-of-humanity-a-decade-of-broken-promises-on-healthcare-in-conflict
  • Breast Cancer Prevention and Lifestyle

A Crisis of Humanity: A Decade of Broken Promises on Healthcare in Conflict

Sagoh August 7, 2025 0
Ten years ago, the international community stood in the chambers of the United Nations Security Council and...
Read More Read more about A Crisis of Humanity: A Decade of Broken Promises on Healthcare in Conflict
From Spreadsheets to Strategy: How AI is Overhauling the $5.9 Million Clinical Data Bottleneck from-spreadsheets-to-strategy-how-ai-is-overhauling-the-5-9-million-clinical-data-bottleneck
  • Treatment Innovations

From Spreadsheets to Strategy: How AI is Overhauling the $5.9 Million Clinical Data Bottleneck

Pevita Pearce August 4, 2025 0
In the high-stakes world of pharmaceutical development, where a single Phase 3 clinical trial can represent billions...
Read More Read more about From Spreadsheets to Strategy: How AI is Overhauling the $5.9 Million Clinical Data Bottleneck
Decoding the Blueprint of Breast Cancer: Dr. Jennifer Asmussen and the Future of Genomic Risk Assessment decoding-the-blueprint-of-breast-cancer-dr-jennifer-asmussen-and-the-future-of-genomic-risk-assessment
  • Genomics and Precision Medicine

Decoding the Blueprint of Breast Cancer: Dr. Jennifer Asmussen and the Future of Genomic Risk Assessment

Jia Lissa August 3, 2025 0
In the landscape of modern medicine, few challenges are as persistent as breast cancer. Affecting approximately one...
Read More Read more about Decoding the Blueprint of Breast Cancer: Dr. Jennifer Asmussen and the Future of Genomic Risk Assessment
The Silent Language of Support: Navigating Friendship During a Cancer Diagnosis the-silent-language-of-support-navigating-friendship-during-a-cancer-diagnosis
  • Psychosocial Support and Mental Health

The Silent Language of Support: Navigating Friendship During a Cancer Diagnosis

Asep Darmawan July 27, 2025 0
When a close friend receives a cancer diagnosis, the immediate instinct for most of us is a...
Read More Read more about The Silent Language of Support: Navigating Friendship During a Cancer Diagnosis
Navigating the Hardest Conversation: A Guide for Families Facing Terminal Illness navigating-the-hardest-conversation-a-guide-for-families-facing-terminal-illness
  • Survivorship and Post-Treatment

Navigating the Hardest Conversation: A Guide for Families Facing Terminal Illness

Dwi Wanna July 24, 2025 0
Written by Kelsey Mora, Certified Child Life Specialist (CCLS), Licensed Clinical Professional Counselor (LCPC), and Chief Clinical...
Read More Read more about Navigating the Hardest Conversation: A Guide for Families Facing Terminal Illness
Breakthrough in Pathology: New Molecular Markers Identified to Distinguish Between Rare Langerhans Cell Neoplasms breakthrough-in-pathology-new-molecular-markers-identified-to-distinguish-between-rare-langerhans-cell-neoplasms
  • Clinical Radiology and Imaging

Breakthrough in Pathology: New Molecular Markers Identified to Distinguish Between Rare Langerhans Cell Neoplasms

Layla Zulfa July 23, 2025 0
Main Facts: Solving a Diagnostic Dilemma Langerhans cell sarcoma (LCS) is an exceptionally rare, highly aggressive malignant...
Read More Read more about Breakthrough in Pathology: New Molecular Markers Identified to Distinguish Between Rare Langerhans Cell Neoplasms
The Vanguard of Hope: How Breast Cancer Canada is Redefining the Patient Experience through Innovation and Research the-vanguard-of-hope-how-breast-cancer-canada-is-redefining-the-patient-experience-through-innovation-and-research
  • Global Breast Cancer Awareness

The Vanguard of Hope: How Breast Cancer Canada is Redefining the Patient Experience through Innovation and Research

Nila Kartika Wati July 12, 2025 0
Introduction: A New Era in Oncology In the landscape of modern medicine, the fight against breast cancer...
Read More Read more about The Vanguard of Hope: How Breast Cancer Canada is Redefining the Patient Experience through Innovation and Research

Posts pagination

Previous 1 … 155 156 157 158

Recent Posts

  • The Bispecific Gold Rush: Are Pharma Giants Targeting the Wrong Cancer Frontier?
  • Navigating the Frontier of Precision Oncology: The Clinical Integration of Zolbetuximab in Gastric Cancer Care
  • The Final Reconciliation: How One Daughter Found Healing in the Shadow of Terminal Illness
  • Beyond the Pink Ribbon: Why Men Must Be Part of the BRCA Conversation
  • From Isolation to Empowerment: How Shanti’s PACT Program Transformed Edith’s Life

Recent Comments

No comments to show.

Archives

  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-bispecific-gold-rush-are-pharma-giants-targeting-the-wrong-cancer-frontier
  • Treatment Innovations

The Bispecific Gold Rush: Are Pharma Giants Targeting the Wrong Cancer Frontier?

Azzam Bilal Chamdy June 6, 2026
navigating-the-frontier-of-precision-oncology-the-clinical-integration-of-zolbetuximab-in-gastric-cancer-care
  • Clinical Oncology Education

Navigating the Frontier of Precision Oncology: The Clinical Integration of Zolbetuximab in Gastric Cancer Care

Azzam Bilal Chamdy June 6, 2026
the-final-reconciliation-how-one-daughter-found-healing-in-the-shadow-of-terminal-illness
  • Survivorship and Post-Treatment

The Final Reconciliation: How One Daughter Found Healing in the Shadow of Terminal Illness

Asep Darmawan June 6, 2026
beyond-the-pink-ribbon-why-men-must-be-part-of-the-brca-conversation
  • Survivorship and Post-Treatment

Beyond the Pink Ribbon: Why Men Must Be Part of the BRCA Conversation

Suro Senen June 6, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.